These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Short-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients. Ormerod JO; Arif S; Mukadam M; Evans JD; Beadle R; Fernandez BO; Bonser RS; Feelisch M; Madhani M; Frenneaux MP Circ Heart Fail; 2015 May; 8(3):565-71. PubMed ID: 25838311 [TBL] [Abstract][Full Text] [Related]
52. Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study. López-Candales A; Vora T; Gibbons W; Carron C; Simmons P; Schwartz J J Med; 2002; 33(1-4):129-46. PubMed ID: 12939113 [TBL] [Abstract][Full Text] [Related]
53. Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure. Mitrovic V; Willenbrock R; Miric M; Seferovic P; Spinar J; Dabrowski M; Kiowski W; Marks DS; Alegria E; Dukát A; Lenz K; Arens HA Am Heart J; 2003 Mar; 145(3):E14. PubMed ID: 12660683 [TBL] [Abstract][Full Text] [Related]
54. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure. Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864 [TBL] [Abstract][Full Text] [Related]
56. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation. Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469 [TBL] [Abstract][Full Text] [Related]
57. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure. Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794 [TBL] [Abstract][Full Text] [Related]
58. Catecholamine support at the initiation of epoprostenol therapy in pulmonary arterial hypertension. Akagi S; Ogawa A; Miyaji K; Kusano K; Ito H; Matsubara H Ann Am Thorac Soc; 2014 Jun; 11(5):719-27. PubMed ID: 24716663 [TBL] [Abstract][Full Text] [Related]
59. Effects of continuous intravenous epoprostenol therapy on advanced primary pulmonary hypertension in Taiwanese patients. Hsu HH; Chen JS; Kuo SH; Chiang FT; Ko WJ; Kuo SW; Huang SC; Lee YC J Formos Med Assoc; 2005 Jan; 104(1):60-3. PubMed ID: 15660181 [TBL] [Abstract][Full Text] [Related]
60. Vasodilator therapy with a new stable prostacyclin analog, OP-41483, for congestive heart failure due to coronary artery disease and comparison of hemodynamic effects and platelet aggregation with nitroprusside. Yui Y; Takatsu Y; Hattori R; Susawa T; Sakaguchi K; Yui N; Kawai C Am J Cardiol; 1986 Nov; 58(10):1042-5. PubMed ID: 3535472 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]